Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Panton-Valentine leukocidin subunit S (LukS-PV) is one component of the bicomponent Panton-Valentine leukocidin (PVL) toxin produced by Staphylococcus aureus. It works in conjunction with the F subunit (LukF-PV) to form pores in the membranes of host cells, particularly leukocytes. The protein has a structure consisting of three functional subdomains: a central β-sandwich, a protruding rim, and a stem domain that is critical for pore formation[1][3]. LukS-PV specifically binds to the human C5a receptor (hC5aR1) on target cells, while LukF-PV interacts with CD45, and together they form an octameric pore structure with alternating S and F components[4]. This pore formation leads to cell lysis and contributes to the pathogenicity of PVL-producing S. aureus strains. The signal peptide of LukS-PV has been shown to mediate increased adhesion to heparan sulfates[5]. LukS-PV has been directly implicated in the pathophysiology of necrotizing pneumonia, where it can be detected in lung sections of affected patients. It induces apoptosis by targeting mitochondria, causing the release of cytochrome c and other pro-apoptotic factors, leading to caspase activation and DNA fragmentation[2]. This process occurs independently of Bax, a pro-apoptotic protein typically involved in mitochondrial pore formation.
Forms heterooligomeric pores with LukF-PV in target cell membranes Binds to C5a receptor (hC5aR1) on target cells Interacts with heparan sulfates via signal peptide Targets mitochondria to induce apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Panton-Valentine leukocidin subunit S (LukS-PV).